Clinical Trial Update: Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL [Phase 1, Phase 2]

View source ↗

Summary

The document reports on a CHOP-R-like regimen (cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab) tested in aggressive non-Hodgkin lymphoma acro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Cyclophosphamide (Cytoxan) (cyclophosphamide)
• Doxorubicin (Adriamycin) (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (Rituxan) (rituximab)
• Vincristine (Oncovin) (Vincristine)

Snippet

Sponsor: Fernando Cabanillas | Conditions: Lymphoma, Non Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: COMPLETED